Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Jacobson

Showing results (321-330 of 599) with videos related to

Pageof 60
Sort By:
Purinergic Signalling|February 28, 2024
Genetic and functional modulation by agonist MRS5698 and allosteric enhancer LUF6000 at the native A<sub>3</sub> adenosine receptor in HL-60 cellsZhan-Guo Gao, Weiping Chen, Ray R Gao, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2009
Synthesis and P2Y receptor activity of nucleoside 5'-phosphonate derivativesLiesbet Cosyn, Serge Van Calenbergh, Bhalchandra V Joshi, et al.
Biochemical Pharmacology|February 5, 2003
Differential allosteric modulation by amiloride analogues of agonist and antagonist binding at A(1) and A(3) adenosine receptorsZhan-Guo Gao, Neli Melman, Andreas Erdmann, et al.
The Journal of Biological Chemistry|August 12, 2005
Identification of an agonist-induced conformational change occurring adjacent to the ligand-binding pocket of the M(3) muscarinic acetylcholine receptorSung-Jun Han, Fadi F Hamdan, Soo-Kyung Kim, et al.
Journal of Medicinal Chemistry|March 3, 2010
Structure-activity relationship of (N)-Methanocarba phosphonate analogues of 5'-AMP as cardioprotective agents acting through a cardiac P2X receptorT Santhosh Kumar, Si-Yuan Zhou, Bhalchandra V Joshi, et al.
Purinergic Signalling|June 10, 2022
Fluorescent A<sub>2A</sub> and A<sub>3</sub> adenosine receptor antagonists as flow cytometry probesKiran S Toti, Ryan G Campbell, Hobin Lee, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 22, 2008
Role of P2X purinergic receptors in the rescue of ischemic heart failureDmitry Sonin, Si-Yuan Zhou, Chunxia Cronin, et al.
Biochemical Pharmacology|July 14, 2007
Role of adenosine A3 receptors on CA1 hippocampal neurotransmission during oxygen-glucose deprivation episodes of different durationAnna Maria Pugliese, Elisabetta Coppi, Rosaria Volpini, et al.
Journal of Medicinal Chemistry|December 22, 2005
Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotectionKenneth A Jacobson, Zhan-Guo Gao, Susanna Tchilibon, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2020
Lack of adipocyte purinergic P2Y<sub>6</sub> receptor greatly improves whole body glucose homeostasisShanu Jain, Sai P Pydi, Kiran S Toti, et al.
Pageof 60

Showing results (321-330 of 599) with videos related to

Sort By:
Pageof 60
Purinergic Signalling|February 28, 2024
Genetic and functional modulation by agonist MRS5698 and allosteric enhancer LUF6000 at the native A<sub>3</sub> adenosine receptor in HL-60 cellsZhan-Guo Gao, Weiping Chen, Ray R Gao, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2009
Synthesis and P2Y receptor activity of nucleoside 5'-phosphonate derivativesLiesbet Cosyn, Serge Van Calenbergh, Bhalchandra V Joshi, et al.
Biochemical Pharmacology|February 5, 2003
Differential allosteric modulation by amiloride analogues of agonist and antagonist binding at A(1) and A(3) adenosine receptorsZhan-Guo Gao, Neli Melman, Andreas Erdmann, et al.
The Journal of Biological Chemistry|August 12, 2005
Identification of an agonist-induced conformational change occurring adjacent to the ligand-binding pocket of the M(3) muscarinic acetylcholine receptorSung-Jun Han, Fadi F Hamdan, Soo-Kyung Kim, et al.
Journal of Medicinal Chemistry|March 3, 2010
Structure-activity relationship of (N)-Methanocarba phosphonate analogues of 5'-AMP as cardioprotective agents acting through a cardiac P2X receptorT Santhosh Kumar, Si-Yuan Zhou, Bhalchandra V Joshi, et al.
Purinergic Signalling|June 10, 2022
Fluorescent A<sub>2A</sub> and A<sub>3</sub> adenosine receptor antagonists as flow cytometry probesKiran S Toti, Ryan G Campbell, Hobin Lee, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 22, 2008
Role of P2X purinergic receptors in the rescue of ischemic heart failureDmitry Sonin, Si-Yuan Zhou, Chunxia Cronin, et al.
Biochemical Pharmacology|July 14, 2007
Role of adenosine A3 receptors on CA1 hippocampal neurotransmission during oxygen-glucose deprivation episodes of different durationAnna Maria Pugliese, Elisabetta Coppi, Rosaria Volpini, et al.
Journal of Medicinal Chemistry|December 22, 2005
Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotectionKenneth A Jacobson, Zhan-Guo Gao, Susanna Tchilibon, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2020
Lack of adipocyte purinergic P2Y<sub>6</sub> receptor greatly improves whole body glucose homeostasisShanu Jain, Sai P Pydi, Kiran S Toti, et al.
Pageof 60